The Global Adeno-Associated Virus (AAV) Gene Therapy Market was valued at USD 4.8 billion in 2024 and is expected to reach USD 23.6 billion by 2032 with a CAGR of 24.1% over the forecast period. The Report features a comprehensive table of contents...
Markdown supported · ⌘↵ to post
No responses yet.